Previous 10 | Next 10 |
home / stock / bayry / bayry news
The earnings season came to a close and markets were mostly flat. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks. Whether it is a bubble or not, I won't stop investing. My dividend income from 37 corporations amounted...
The market's view of Bayer. Potential consequences of the growing list of risks. The Bull case or why Bayer put itself into this situation. What we need for a re-rating of the shares. For further details see: Bayer: Bear Vs. Bull
Bayer looks cheaper than it really is. The Monsanto acquisition was more about a transformation than about increasing earnings. Why the guidance cut led to yet another sell-off. For further details see: Bayer: Risks Abound, But An Opportunity Might Arise
Biogen (BIIB) and collaboration partner Samsung Bioepis announce the filing of a marketing application in Europe seeking approval of SB11, a biosimilar to Roche's (RHHBY) retinal vascular disorder med Lucentis (ranibizumab injection).Under their 2019 agreement, they are also developing SB15, ...
High debt levels, a damaged reputation, a potential ban of glyphosate and high settlement payments are putting Bayer in a tough position. Bayer is also feeling pressure from COVID-19, but the business remains recession-proof and has a wide economic moat. At the current share price...
Bayer ([[BAYRY]] -7.6%) tumbles in the U.S. and falls as much as 13% in Frankfurt, after it set new guidance and announced an additional €1.5B in cost cuts amid weaker than expected demand for agricultural products due to the pandemic.The company now foresees FY 2021 sales to finish fl...
Bayer ([[BAYRY]] -3.3%) shares turn sharply lower after the company says it plans a further €1.5B ($1.76B) of annual costs and may cut jobs, as the pandemic slams the agricultural market.The savings goal is on top of annual earnings contributions of €2.6B as of 2022, which was a...
Bayer ([[BAYRY]] +0.4%) says the European Commission authorized its XtendFlex soybean technology for food, feed, import and processing in the European Union.With the EU's approval, the company says it is planning a full launch of the soybeans in the U.S. and Canada in 2021 and will be ready t...
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with this event. For further details see: Bayer (BAYRY) ESG Investor Conference - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...